MedPath

JAMP-PRAVASTATIN

JAMP-PRAVASTATIN

Approved
DIN Number

02330954

Drug Class

Human

Market Date

Apr 1, 2010

Company
HC

Jamp Pharma Corporation

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02330954
AIG Number0122563001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C10AA03 PRAVASTATIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:06.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

PRAVASTATIN SODIUMActive
Strength: 10 MG
Monograph: PRAVASTATIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.